Cardiovascular disease remains the leading cause of death among women, yet it is often underdiagnosed due to atypical symptoms, said Dr. Robin Conley of Baptist ...

The month of February is set aside as American Heart Month, a time to raise awareness about heart disease and the importance ...

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about ...

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance ...

New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...

"Our findings in this study leave no room for doubt," said University of São Paulo researcher Isabela Benseñor.

Q4 2024 Earnings Call Transcript February 20, 2025 Prothena Corporation plc misses on earnings expectations. Reported EPS is ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complications due to its invasive nature. Researchers have now found a way to ...

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature. Researchers have now found a way to ...

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in ...